ALPORT SYNDROME

Clinical trials for ALPORT SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ALPORT SYNDROME trials appear

Sign up with your email to follow new studies for ALPORT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 1 Completed 7 Terminated 1

Experimental kidney drug for alport syndrome falls short in early trial

Disease control Terminated

This phase 2 trial tested a weekly injection of lademirsen in 43 adults with Alport syndrome, a genetic condition that damages kidneys. The goal was to see if the drug could slow the decline in kidney function. The study was terminated early, so the results are limited and it's u…

Matched conditions: ALPORT SYNDROME

Phase: PHASE2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control

Last updated Jun 26, 2026 16:08 UTC

ALPORT SYNDROME

Get alerted when new ALPORT SYNDROME trials appear

Experimental kidney drug for alport syndrome falls short in early trial